Decoding 18 Analyst Evaluations For Boston Scientific
Portfolio Pulse from Benzinga Insights
In the last three months, 18 analysts have provided ratings for Boston Scientific (NYSE:BSX), with a majority being bullish or somewhat bullish. The average 12-month price target has increased to $81.22, with a high estimate of $90.00 and a low estimate of $72.00. Recent analyst actions have predominantly involved raising ratings and price targets.
May 15, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific has received predominantly bullish ratings from 18 analysts over the past three months, with the average 12-month price target increasing to $81.22. This indicates positive sentiment and potential for stock price appreciation.
The majority of analysts have raised their ratings and price targets for Boston Scientific, reflecting positive sentiment and expectations for stock price growth. The increase in the average price target to $81.22 further supports this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100